Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2023-06-23 00:00:00 ET · period of report 2023-06-21 · accession 0001104659-23-074060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-23 | 2023-06-21+ | NVCT | Mosseri Marlio Charles | 10% | P - Purchase | $17.72 | +13.1K | 2.44M | +0.5% | +$232.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-21 | P | A | 6,091 | $17.71 | 2,431,091 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-22 | P | A | 6,999 | $17.73 | 2,438,090 | D | — | — |